Outcomes of autologous bone marrow mononuclear cell administration combined with educational intervention in the treatment of autism spectrum disorder: a randomized, open-label, controlled phase II clinical trial

Abstract Background This study evaluated the effectiveness of intrathecal autologous bone marrow mononuclear cell (BMMNC) therapy combined with education compared with education alone for the treatment of autism spectrum disorder (ASD). Methods Fifty-four children with ASD, aged three to seven years...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Liem Thanh Nguyen, Phuong Mai Nguyen, Hoang-Phuong Nguyen, Hau Thi Bui, Lan Thi Mai Dao, Minh Van Pham, Chi Khanh Hoang, Phuong Thi Nguyen, Thao Thi Phuong Nguyen, Anh Thi Phuong Nguyen, Van Thi Hoang, Hoa Thi Phuong Bui, Ngan Kim Vuong, Doan Van Ngo
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2025-05-01
سلاسل:	Stem Cell Research & Therapy
الموضوعات:	Autism spectrum disorder Bone marrow mononuclear cells Intrathecal infusion Randomized phase II clinical trial Cell therapy
الوصول للمادة أونلاين:	https://doi.org/10.1186/s13287-025-04404-4
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!